<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Abnormalities of chromosome 16 other than inv(16)(p13q22), t(16;16)(p13;q22), and del(16)(q22) have not been fully characterized in <z:hpo ids='HP_0004808'>acute myeloblastic leukemia</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>) and <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) </plain></SENT>
<SENT sid="1" pm="."><plain>We report here the first case of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> with del(16)(q11) as a sole abnormality </plain></SENT>
<SENT sid="2" pm="."><plain>A 53-year-old woman was initially diagnosed as <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>, <z:hpo ids='HP_0005505'>refractory anemia</z:hpo> with excess of blasts in transformation with <z:mpath ids='MPATH_458'>normal</z:mpath> karyotype </plain></SENT>
<SENT sid="3" pm="."><plain>After sixteen months, the disease progressed to overt <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>-M1 </plain></SENT>
<SENT sid="4" pm="."><plain>Myeloblasts were positive for CD13, CD33, and CD34, but negative for HLA-DR </plain></SENT>
<SENT sid="5" pm="."><plain>Chromosome analyses of the bone marrow cells showed 46,XX,del(16)(q11) in <z:hpo ids='HP_0000001'>all</z:hpo> metaphase spreads </plain></SENT>
<SENT sid="6" pm="."><plain>Multicolor spectral karyotyping also confirmed that del(16)(q11) was not derived from a cryptic translocation, but a simple deletion </plain></SENT>
<SENT sid="7" pm="."><plain>Our results, together with three previously reported cases, suggest that del(16)(q11) may be one of the recurrent aberrations in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> and that it could be associated with <z:e sem="disease" ids="C1516669" disease_type="Neoplastic Process" abbrv="">clonal evolution</z:e> or disease progression </plain></SENT>
</text></document>